The Ketogenic Diet: Evidence for Optimism but High-Quality Research Needed.
Level 5 - mechanism / opinion, no new human data
Narrative review and expert opinion without systematic review methodology or new human data.
PubMed 31825066 · doi:10.1093/jn/nxz308
What was done
This paper is a narrative review and perspective examining the rationale, safety, and therapeutic application of very-low-carbohydrate ketogenic diets (with fat comprising >70% of calories) compared with traditional low-fat dietary recommendations for obesity, diabetes, and conditions associated with insulin resistance.
What was found
The abstract reports no primary quantitative data, sample sizes, or statistical metrics. It states qualitatively that ketogenic diets reduce blood glucose and insulin, appear more effective than low-fat diets for obesity and diabetes, do not show major safety concerns when well-formulated, and may confer unique metabolic benefits in cancer and neurodegenerative diseases.
Why it matters
The paper synthesizes physiological arguments for using nutritional ketosis as a legitimate first-line approach in metabolic disease management rather than dismissing it as a dietary fad.
Limits
The work is a narrative review and expert commentary rather than an empirical trial or systematic review. It reports no original data or quantitative risk-benefit estimates, and explicitly notes that high-quality clinical trials evaluating long-term effects are currently lacking.
Cited by
- supports A standard ketogenic diet consists of 70% to 75% calories from fat, 20% from protein, and 5% to 10% (under 20 to 50 grams per day) from carbohydrates.